1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Gene Sequencing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Emulsion Polymerase Chain Reaction
1.2.3 Bridge Amplification
1.2.4 Single Molecule
1.3 Market by Application
1.3.1 Global Human Gene Sequencing Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals and Clinics
1.3.3 Independent Clinical Laboratories
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Human Gene Sequencing Market Perspective (2017-2028)
2.2 Human Gene Sequencing Growth Trends by Region
2.2.1 Human Gene Sequencing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Human Gene Sequencing Historic Market Size by Region (2017-2022)
2.2.3 Human Gene Sequencing Forecasted Market Size by Region (2023-2028)
2.3 Human Gene Sequencing Market Dynamics
2.3.1 Human Gene Sequencing Industry Trends
2.3.2 Human Gene Sequencing Market Drivers
2.3.3 Human Gene Sequencing Market Challenges
2.3.4 Human Gene Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Gene Sequencing Players by Revenue
3.1.1 Global Top Human Gene Sequencing Players by Revenue (2017-2022)
3.1.2 Global Human Gene Sequencing Revenue Market Share by Players (2017-2022)
3.2 Global Human Gene Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Gene Sequencing Revenue
3.4 Global Human Gene Sequencing Market Concentration Ratio
3.4.1 Global Human Gene Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Gene Sequencing Revenue in 2021
3.5 Human Gene Sequencing Key Players Head office and Area Served
3.6 Key Players Human Gene Sequencing Product Solution and Service
3.7 Date of Enter into Human Gene Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Gene Sequencing Breakdown Data by Type
4.1 Global Human Gene Sequencing Historic Market Size by Type (2017-2022)
4.2 Global Human Gene Sequencing Forecasted Market Size by Type (2023-2028)
5 Human Gene Sequencing Breakdown Data by Application
5.1 Global Human Gene Sequencing Historic Market Size by Application (2017-2022)
5.2 Global Human Gene Sequencing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Human Gene Sequencing Market Size (2017-2028)
6.2 North America Human Gene Sequencing Market Size by Country (2017-2022)
6.3 North America Human Gene Sequencing Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Human Gene Sequencing Market Size (2017-2028)
7.2 Europe Human Gene Sequencing Market Size by Country (2017-2022)
7.3 Europe Human Gene Sequencing Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Gene Sequencing Market Size (2017-2028)
8.2 Asia-Pacific Human Gene Sequencing Market Size by Country (2017-2022)
8.3 Asia-Pacific Human Gene Sequencing Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Human Gene Sequencing Market Size (2017-2028)
9.2 Latin America Human Gene Sequencing Market Size by Country (2017-2022)
9.3 Latin America Human Gene Sequencing Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Gene Sequencing Market Size (2017-2028)
10.2 Middle East & Africa Human Gene Sequencing Market Size by Country (2017-2022)
10.3 Middle East & Africa Human Gene Sequencing Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 10x Genomics
11.1.1 10x Genomics Company Detail
11.1.2 10x Genomics Business Overview
11.1.3 10x Genomics Human Gene Sequencing Introduction
11.1.4 10x Genomics Revenue in Human Gene Sequencing Business (2017-2022)
11.1.5 10x Genomics Recent Development
11.2 23andME
11.2.1 23andME Company Detail
11.2.2 23andME Business Overview
11.2.3 23andME Human Gene Sequencing Introduction
11.2.4 23andME Revenue in Human Gene Sequencing Business (2017-2022)
11.2.5 23andME Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Human Gene Sequencing Introduction
11.3.4 Abbott Revenue in Human Gene Sequencing Business (2017-2022)
11.3.5 Abbott Recent Development
11.4 AccuraGen
11.4.1 AccuraGen Company Detail
11.4.2 AccuraGen Business Overview
11.4.3 AccuraGen Human Gene Sequencing Introduction
11.4.4 AccuraGen Revenue in Human Gene Sequencing Business (2017-2022)
11.4.5 AccuraGen Recent Development
11.5 Adaptive Biotechnologies
11.5.1 Adaptive Biotechnologies Company Detail
11.5.2 Adaptive Biotechnologies Business Overview
11.5.3 Adaptive Biotechnologies Human Gene Sequencing Introduction
11.5.4 Adaptive Biotechnologies Revenue in Human Gene Sequencing Business (2017-2022)
11.5.5 Adaptive Biotechnologies Recent Development
11.6 Admera Health
11.6.1 Admera Health Company Detail
11.6.2 Admera Health Business Overview
11.6.3 Admera Health Human Gene Sequencing Introduction
11.6.4 Admera Health Revenue in Human Gene Sequencing Business (2017-2022)
11.6.5 Admera Health Recent Development
11.7 Agena Bioscience
11.7.1 Agena Bioscience Company Detail
11.7.2 Agena Bioscience Business Overview
11.7.3 Agena Bioscience Human Gene Sequencing Introduction
11.7.4 Agena Bioscience Revenue in Human Gene Sequencing Business (2017-2022)
11.7.5 Agena Bioscience Recent Development
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Detail
11.8.2 Agilent Technologies Business Overview
11.8.3 Agilent Technologies Human Gene Sequencing Introduction
11.8.4 Agilent Technologies Revenue in Human Gene Sequencing Business (2017-2022)
11.8.5 Agilent Technologies Recent Development
11.9 Akonni Biosystems
11.9.1 Akonni Biosystems Company Detail
11.9.2 Akonni Biosystems Business Overview
11.9.3 Akonni Biosystems Human Gene Sequencing Introduction
11.9.4 Akonni Biosystems Revenue in Human Gene Sequencing Business (2017-2022)
11.9.5 Akonni Biosystems Recent Development
11.10 Ancestry
11.10.1 Ancestry Company Detail
11.10.2 Ancestry Business Overview
11.10.3 Ancestry Human Gene Sequencing Introduction
11.10.4 Ancestry Revenue in Human Gene Sequencing Business (2017-2022)
11.10.5 Ancestry Recent Development
11.11 AnchorDx
11.11.1 AnchorDx Company Detail
11.11.2 AnchorDx Business Overview
11.11.3 AnchorDx Human Gene Sequencing Introduction
11.11.4 AnchorDx Revenue in Human Gene Sequencing Business (2017-2022)
11.11.5 AnchorDx Recent Development
11.12 Arc Bio
11.12.1 Arc Bio Company Detail
11.12.2 Arc Bio Business Overview
11.12.3 Arc Bio Human Gene Sequencing Introduction
11.12.4 Arc Bio Revenue in Human Gene Sequencing Business (2017-2022)
11.12.5 Arc Bio Recent Development
11.13 ArcherDx
11.13.1 ArcherDx Company Detail
11.13.2 ArcherDx Business Overview
11.13.3 ArcherDx Human Gene Sequencing Introduction
11.13.4 ArcherDx Revenue in Human Gene Sequencing Business (2017-2022)
11.13.5 ArcherDx Recent Development
11.14 ARUP Laboratories
11.14.1 ARUP Laboratories Company Detail
11.14.2 ARUP Laboratories Business Overview
11.14.3 ARUP Laboratories Human Gene Sequencing Introduction
11.14.4 ARUP Laboratories Revenue in Human Gene Sequencing Business (2017-2022)
11.14.5 ARUP Laboratories Recent Development
11.15 Asuragen
11.15.1 Asuragen Company Detail
11.15.2 Asuragen Business Overview
11.15.3 Asuragen Human Gene Sequencing Introduction
11.15.4 Asuragen Revenue in Human Gene Sequencing Business (2017-2022)
11.15.5 Asuragen Recent Development
11.16 Baylor Genetics
11.16.1 Baylor Genetics Company Detail
11.16.2 Baylor Genetics Business Overview
11.16.3 Baylor Genetics Human Gene Sequencing Introduction
11.16.4 Baylor Genetics Revenue in Human Gene Sequencing Business (2017-2022)
11.16.5 Baylor Genetics Recent Development
11.17 Beckman Coulter
11.17.1 Beckman Coulter Company Detail
11.17.2 Beckman Coulter Business Overview
11.17.3 Beckman Coulter Human Gene Sequencing Introduction
11.17.4 Beckman Coulter Revenue in Human Gene Sequencing Business (2017-2022)
11.17.5 Beckman Coulter Recent Development
11.18 Becton, Dickinson and Company
11.18.1 Becton, Dickinson and Company Company Detail
11.18.2 Becton, Dickinson and Company Business Overview
11.18.3 Becton, Dickinson and Company Human Gene Sequencing Introduction
11.18.4 Becton, Dickinson and Company Revenue in Human Gene Sequencing Business (2017-2022)
11.18.5 Becton, Dickinson and Company Recent Development
11.19 BGI Genomics
11.19.1 BGI Genomics Company Detail
11.19.2 BGI Genomics Business Overview
11.19.3 BGI Genomics Human Gene Sequencing Introduction
11.19.4 BGI Genomics Revenue in Human Gene Sequencing Business (2017-2022)
11.19.5 BGI Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details